Saturday, April 11, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Strategy’s Solitary Bitcoin Bet: A $14.5 Billion Paper Loss and Unwavering Conviction

SiterGedge by SiterGedge
April 11, 2026
in Analysis, Bitcoin, Crypto Stocks, Insider Trading
0
Strategy Stock
0
SHARES
5
VIEWS
Share on FacebookShare on Twitter

As corporate interest in Bitcoin evaporates, one company stands defiantly alone. Software firm Strategy continues to aggressively expand its cryptocurrency holdings, financing a massive buying spree through relentless stock sales even as its multi-billion dollar paper loss deepens. This high-stakes gamble is reshaping the landscape of institutional Bitcoin ownership.

The company’s latest move saw it acquire 4,871 Bitcoin between April 1 and 5, 2026, for approximately $330 million. This purchase, executed at an average price of $67,718 per coin, brings its total treasury to 766,970 BTC. That staggering hoard now represents about 3.8 percent of Bitcoin’s entire circulating supply. The funding mechanism, however, is a familiar point of contention for shareholders. Strategy sold over 1.6 million of its own shares across two tickers—STRC and MSTR—raising roughly $174.6 million to finance the latest acquisition.

This aggressive accumulation has placed Strategy in a league of its own. Data from CryptoQuant reveals a dramatic shift in corporate Bitcoin buying. While firms accounted for 95 percent of purchases as recently as October of last year, their share has collapsed to a mere two percent in 2026. The number of active corporate buyers has plunged by 76 percent, leaving Strategy operating in near isolation. Its relentless pace has even allowed it to close the gap on industry giants. Since January, the company has added nearly 90,000 Bitcoin to its balance sheet, a rate that has outpaced the net inflows into BlackRock’s IBIT ETF by a factor of seven. The deficit to the largest holder has now shrunk to around 20,000 coins.

The financial toll of this strategy is stark. Strategy’s average cost basis across its entire Bitcoin portfolio sits at $75,644 per coin, well above the current market price of approximately $69,100. This discrepancy has created a significant unrealized loss. For the first quarter of 2026, the company reported an accounting loss on its digital assets of $14.46 billion, against which it holds a deferred tax asset of $2.42 billion. On a mark-to-market basis, the paper loss is estimated at around $5 billion.

Should investors sell immediately? Or is it worth buying Strategy?

The potential for further share dilution remains a structural feature of this business model. Existing at-the-market offering programs still have massive capacity, with $27.1 billion remaining for MSTR shares and another $22.6 billion for STRC stock. Should Strategy maintain its current monthly investment rate of roughly $2.3 billion, some models project it could cross the historic threshold of one million Bitcoin held as early as November 2026.

Amid this corporate buying frenzy, an insider transaction occurred. Director Jarrod M. Patten exercised options for 2,100 shares at $18.65 each on April 7 and 8, subsequently selling them on the open market at prices between $123 and $132. He retains direct ownership of 28,000 shares following these transactions.

Market sentiment on the stock reflects the high-risk nature of the bet. While recent Bitcoin purchases provided a short-term lift, the share price is down 18.55 percent year-to-date. Analyst opinions are deeply divided. The 14 analysts covering the stock with buy ratings have an average price target of $374, but their forecasts range wildly from a low of $175 to a high of $705. This extreme variance underscores the challenge of valuing a company whose fortune is now inextricably linked to the volatility of a single digital asset.

Ad

Strategy Stock: Buy or Sell?! New Strategy Analysis from April 11 delivers the answer:

The latest Strategy figures speak for themselves: Urgent action needed for Strategy investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from April 11.

Strategy: Buy or sell? Read more here...

Tags: Strategy
SiterGedge

SiterGedge

Related Posts

ImmunityBio Stock
Analysis

ImmunityBio’s Record Revenue Meets Mounting Legal Pressure

April 11, 2026
Fermi Stock
Analysis

Fermi’s Texas Power Gamble Faces Investor Exodus and Delays

April 10, 2026
Coinbase Stock
Analysis

Coinbase Faces a Volatility Trap as Trading Slumps and New Products Launch

April 10, 2026
Next Post
ImmunityBio Stock

ImmunityBio's Record Revenue Meets Mounting Legal Pressure

Recommended

Infineon Stock

Infineon’s Strategic Pivot Amid Rising Asian Competition in Power Semiconductors

3 weeks ago
Asbury Automotive Stock

Asbury Automotive’s Expansion Strategy Faces Market Skepticism

8 months ago
ePlus Stock

ePlus Stock: A Quiet Transformation Gains Momentum

7 months ago
Rimini Stock

Rimini Street Stock: Executive Sales Cloud Strong Growth Narrative

7 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Shadow Banks, Record Defaults, and the $1.8 Trillion Fracture

Orora’s Strategic Pivot: Shifting Glass Production from the Middle East to Mexico

Fermi’s Texas Power Gamble Faces Investor Exodus and Delays

iShares MSCI World ETF: Stability Anchored by a Handful of Tech Titans

Coinbase Faces a Volatility Trap as Trading Slumps and New Products Launch

Ams Osram’s Gold Problem Meets AI Optimism

Trending

ImmunityBio Stock
Analysis

ImmunityBio’s Record Revenue Meets Mounting Legal Pressure

by Jackson Burston
April 11, 2026
0

ImmunityBio's stock is navigating a volatile path, caught between explosive commercial growth for its bladder cancer drug...

Strategy Stock

Strategy’s Solitary Bitcoin Bet: A $14.5 Billion Paper Loss and Unwavering Conviction

April 11, 2026
BioNTech Stock

BioNTech’s Oncology Drive Gains Momentum with Key Data and Analyst Backing

April 11, 2026
Shadow Banks, Record Defaults, and the $1.8 Trillion Fracture

Shadow Banks, Record Defaults, and the $1.8 Trillion Fracture

April 11, 2026
Orora Stock

Orora’s Strategic Pivot: Shifting Glass Production from the Middle East to Mexico

April 10, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • ImmunityBio’s Record Revenue Meets Mounting Legal Pressure
  • Strategy’s Solitary Bitcoin Bet: A $14.5 Billion Paper Loss and Unwavering Conviction
  • BioNTech’s Oncology Drive Gains Momentum with Key Data and Analyst Backing

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com